Looking at what we know , APSEC and Hiscock both invested in the latest raise . It would be fair to assume that larger fund managers are exposed to more company information via private meetings than what you and I are when it comes to extracting money .
Hiscock invested $300,000 as a note and converted it into 100,000,000 shares . Why convert ? They also seemed to have accepted their free option at maturity date 21/6/19 . Note , nowhere does it state that they paid any money for their NOROA option . Why did they have access to the options early ? A take over would be one reason , but we won’t go there .
In house cross trades may be Hiscock distributing the 100 million shares to their investors , these trades have transacted upto 0.0045 per share .
The activity in NOROA shares just before 21/6/19 may have been again in house trades from Hiscock to their investors , shown as 0.001 .
Hiscock are now in a position to profit handsomely while still offering their client a better deal than on market , ie 4 shares @ 0.0045 and 3 options @0.001 average price 0.003 .
Hiscock would profit , 100 million x 0.0015 = $150,000
keep 25 million shares from options , cost nil , sell ??? Say 0.008 $200,000
Hiscock will not want to burn their investors on a company like NOR .
Now at no stage accept any of the above to be true , accurate , partly true or false or partly false , it’is designed to make us all think , what’s really going on .
We need to think and work this out before the next announcement, otherwise we may be lined up behind creature and 88 trying to top up at 0.009
- Forums
- ASX - By Stock
- NOR
- Ann: Becoming a substantial holder
Ann: Becoming a substantial holder, page-237
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOR (ASX) to my watchlist
|
|||||
Last
4.5¢ |
Change
-0.002(4.26%) |
Mkt cap ! $21.37M |
Open | High | Low | Value | Volume |
4.5¢ | 4.5¢ | 4.5¢ | $2.25K | 50K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 85968 | 4.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.5¢ | 68140 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 85968 | 0.043 |
1 | 13888 | 0.041 |
3 | 450000 | 0.039 |
1 | 255000 | 0.038 |
2 | 1375000 | 0.037 |
Price($) | Vol. | No. |
---|---|---|
0.045 | 68140 | 1 |
0.047 | 142144 | 2 |
0.048 | 61184 | 1 |
0.050 | 590074 | 5 |
0.056 | 60000 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
NOR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online